Bone Biologics (BBLGW) Stock Price, News & Analysis

Company Overview

Bone Biologics Holdings, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of next-generation bone repair and regeneration therapies. The company’s proprietary approach leverages naturally occurring human proteins to stimulate targeted osteogenesis in orthopedic and dental applications, aiming to address unmet needs in spinal fusion, fracture healing and dental bone grafting.

Its lead product candidate, NELL-1, is a recombinant human protein designed to promote bone formation with a potential safety profile that may reduce adverse events associated with current bone morphogenetic protein therapies. Bone Biologics has demonstrated robust efficacy in preclinical models and is preparing to advance NELL-1 into early-stage clinical trials. Beyond NELL-1, the company’s pipeline focuses on additional protein-based candidates for critical-size bone defects and related indications.

Headquartered in Alpharetta, Georgia, Bone Biologics collaborates with academic institutions and industry partners to support research and development. The management team brings experience in biologics development, clinical strategy and orthopedic product commercialization. The company plans to pursue strategic partnerships to facilitate late-stage development and regulatory approval in the United States and select global markets.

Key Stats

• Today's Range: $15.00 to $15.00
• 50-Day Range: $13.50 to $15.00
• 52-Week Range: $3.00 to $95.04
• Volume: N/A
• Average Volume: 1,915 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BBLGW Stock Analysis - Frequently Asked Questions

How have BBLGW shares performed this year?

Bone Biologics' stock was trading at $40.00 at the start of the year. Since then, BBLGW shares have decreased by 62.5% and is now trading at $15.00.

When did Bone Biologics' stock split?

Shares of Bone Biologics reverse split on the morning of Wednesday, June 7th 2023.The 1-30 reverse split was announced on Wednesday, June 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, June 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

How do I buy shares of Bone Biologics?

Shares of BBLGW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:BBLGW
• CIK: 1419554
• Web: www.bonebiologics.com
• Phone: 781-552-4452
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A